NCT02322177

Brief Summary

Background: \- People with inborn errors of metabolism can t turn food into energy the right way. This can affect a person s growth and health. Researchers want to know how this condition affects a pregnant woman and her baby. Objectives: \- To collect data from the medical records of women with an inborn error of metabolism. Also, to create a pregnancy registry of inborn errors of metabolism. Eligibility:

  • Women with an inborn error of metabolism who either:
  • have been pregnant in the past,
  • are currently pregnant, or
  • have recently talked with their doctor about becoming pregnant. Design:
  • This study will collect data only. No extra tests will be done.
  • Participants will be in the study for the length of their pregnancy and for 1 year after delivery.
  • Participants will answer questions about their family s health.
  • The participant s doctor will send their medical records to researchers. These may include data about:
  • Last health care visit before pregnancy
  • Blood, urine, ultrasound, or lab results during pregnancy
  • Delivery and recovery after delivery
  • Researchers will ask for the test(s) used to confirm pregnancy.
  • After the participant has her baby, researchers will ask for data about how the baby is doing. This may include when the baby is sitting, walking, talking, etc.
  • The data will be placed into a database. The database will not include the participant s name or identifying data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2014

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2014

Completed
Same day until next milestone

Study Start

First participant enrolled

December 19, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 23, 2014

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2018

Completed
Last Updated

May 1, 2026

Status Verified

September 9, 2025

Enrollment Period

3.7 years

First QC Date

December 19, 2014

Last Update Submit

April 30, 2026

Conditions

Keywords

Inborn Error of MetabolismPregnancyAmino acid disorderFatty acid oxidation disorderOrganic AcidemiaNatural History

Outcome Measures

Primary Outcomes (1)

  • Maternal inborn errors of metabolism

    Yearly

Study Arms (1)

1

Participants are women with inborn errors of metabolism who have been pregnant

Eligibility Criteria

Age14 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Participants are women with inborn errors of metabolism who have been pregnant

You may qualify if:

  • Patients clinically diagnosed with methylmalonic acidemia or another inborn error of metabolism are eligible to participate; mutational and enzymatic status is preferred but not required. Biochemical testing is required.
  • Women with inborn errors of metabolism who have had a clinically documented prior pregnancy, currently are pregnant or planning a pregnancy.

You may not qualify if:

  • Patients with phenylketonuria or hyperphenylalaninemia.
  • Anyone unwilling to provide informed consent (for themselves as adults, or on behalf of their children as minors) or assent.
  • We will review a clinical description from the referring physician about a potential research subject to determine that the subject is appropriate to enter into the study. We reserve the right to exclude cases that are not definitively diagnosed by metabolites and/or molecular genetics or related to our direct research interests. We expect this to be a rare minority.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

National Human Genome Research Institute (NHGRI)

Bethesda, Maryland, 20892, United States

Location

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Publications (2)

  • Kuseyri O, Weissbach A, Bruggemann N, Klein C, Gizewska M, Karall D, Scholl-Burgi S, Romanowska H, Krzywinska-Zdeb E, Monavari AA, Knerr I, Yapici Z, Leuzzi V, Opladen T. Pregnancy management and outcome in patients with four different tetrahydrobiopterin disorders. J Inherit Metab Dis. 2018 Sep;41(5):849-863. doi: 10.1007/s10545-018-0169-0. Epub 2018 Mar 28.

    PMID: 29594647BACKGROUND
  • Raval DB, Merideth M, Sloan JL, Braverman NE, Conway RL, Manoli I, Venditti CP. Methylmalonic acidemia (MMA) in pregnancy: a case series and literature review. J Inherit Metab Dis. 2015 Sep;38(5):839-46. doi: 10.1007/s10545-014-9802-8. Epub 2015 Jan 8.

    PMID: 25567501BACKGROUND

Related Links

MeSH Terms

Conditions

Metabolism, Inborn ErrorsAmino Acid Metabolism, Inborn Errors

Condition Hierarchy (Ancestors)

Genetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Charles P Venditti, M.D.

    National Human Genome Research Institute (NHGRI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2014

First Posted

December 23, 2014

Study Start

December 19, 2014

Primary Completion

August 20, 2018

Study Completion

August 20, 2018

Last Updated

May 1, 2026

Record last verified: 2025-09-09

Locations